NTLA Peers Risk Short Interest 16.11% Shares Short 16.36M Days to Cover 8.75 24M Beta 2.86 Altman Z Score 4.38 Technicals Title 10D SMA 50D SMA 200D SMA Simple Moving Average 16.82 19.89 23.81 Last Price vs SMA -11.94% -25.54% -37.81% ...
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Veeva Systems (VEEV) and Neuren Pharmaceuticals Limited (OtherNURPF) Nov. 11, 2024 at 1:10 a.m. ETon TipRanks.com Veeva Systems: Hold Rating Amid Uncertain Growth Projections and Market Challenges ...
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Genmab (GMAB) and Xoma (XOMA) Aug. 13, 2024 at 10:10 a.m. ETon TipRanks.com XOMA Royalty Corp Q2 2024 Earnings: GAAP EPS of $0.88, Revenue Soars to $11. ... ...
What is the Intellia Therapeutics stock price / share price today? The Intellia Therapeutics stock price is 14.130 USD today. Will NTLA stock price drop / fall? Yes. The Intellia Therapeutics stock price may drop from 14.130 USD to 0.000000000025 USD . The change will be -100.000%. Will ...
19 hours ago Analysts update Nvidia stock price target ahead of earnings This is what could happen next to Nvidia shares. NVDAAMZNMETA Latest Retirement News, Tips & Guides Nov 17, 2024 7:17 PM EST Dave Ramsey warns Americans on Social Security and 401(k)s ...
Name Price 24h% & 7d Volume 24h low 24h high Market Cap P/E Ratio EPS The Trade Desk TTD $119.47— +1.07 $2.83M— $118.19 — $121.44 — $57.79B — 234.25 $0.51 — MongoDB MDB $268.74— +1.98 $1.04M— $265.64 — $271 — $19.85B — 0 -$3.01 — Summit Therapeutics SM...
21 hours ago Top analyst overhauls Tesla stock price target amid post-election surge Filings show Elon Musk spent $130 million supporting Republican candidates in the November election. Tesla stock alone gained $230 billion last week. TSLA
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE) February 6, 2024 | finance.yahoo.com Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference ...
NTLABrendan O'BoyleMon, Nov. 117 Comments Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's DiseaseAVXL, SAVALane SimonianMon, Nov. 11296 Comments Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity TherapiesCRBPMyriam AlvarezMon, ...
Employees463Debt/Eq0.63Sales Y/Y TTM82.71%Profit Margin-2677.90%Recom1.36Target Price10.70 Option/ShortYes / YesLT Debt/Eq0.62EPS Q/Q-17.08%Payout-Rel Volume2.19Prev Close3.29 Sales Surprise-100.00%EPS Surprise-44.66%Sales Q/Q-100.00%EarningsNov 12 BMOAvg Volume1.20MPrice3.01 ...